Blue Earth Diagnostics Receives Positive Opinion For Axumin (Fluciclovine (18F)) For PET Imaging Of Recurrent Prostate Cancer Post author:Sam Post published:March 23, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like After FDA Rejection, Bay Area's Coherus Axes 30% of Employees June 27, 2017 Boehringer Ingelheim Initiates Phase IIa Study Of Compound Acquired From Pharmaxis In Debilitating Liver Disease NASH August 24, 2017 Immunomedics Announces Fiscal 2017 Results And Strategic Developments; Reiterates Guidance On BLA Submission Timeline August 16, 2017
Boehringer Ingelheim Initiates Phase IIa Study Of Compound Acquired From Pharmaxis In Debilitating Liver Disease NASH August 24, 2017
Immunomedics Announces Fiscal 2017 Results And Strategic Developments; Reiterates Guidance On BLA Submission Timeline August 16, 2017